While no increase was found in COL5A2 expression after treatment with β-estradiol or in COL5A2 and LAMA4 after treatment with TGFβ in ER-positive and -negative breast carcinoma cells, respectively, all other gene expression levels increased significantly after treatments (Figure S4). This evidence concerns the gene TGFB1 and breast carcinoma.